大麻 - Marijuana, Japanese Sacred Herb

2018.03.29

　健康志向者が増えているアメリカでは、多くの国民が、遺伝子組み換え食品や農薬の質について過敏になっている。特に、こうした部門で有名になったアメリカのモンサント社や、ドイツの医療大手バイエル社に対して警戒心を持つ人も少なくない。

■バイエルによるモンサント買収の裏事情

　2016年9月、この2社のM＆Aが発表され、その内容はバイエルがモンサントを660憶ドル（約6兆8000億円）で買収する、というものだった。

　通常、M＆A後の新体制下では、買われる側の企業の方が弱い立場にあると見られがちだが、健康志向者の間では、モンサントにしてみればこのM＆Aは「不健康かつ不穏な」独自路線を貫ける絶好のチャンスなのだろう、と皮肉な意見が出てくる有り様だったという。どういうことか？

　もともとモンサントは、健康志向者から「環境最悪企業」と揶揄されるほどのマイナスイメージを抱えていた。ところが、そのモンサントにしてみれば、世界を代表する医療企業に買われることにより、今まで着ていた古服を脱ぎ捨てて衣替えできるというメリットがある。モンサントは別の会社に買われることにより、過去のイメージから脱皮でき、新たな着ぐるみに身を包みながら、今までできなかった分野に手を出せるのだ。

　オルタナティブ系メディア「Collective Evolution」によると、医療業界ビッグ4に君臨するバイエルに買われることを選択したモンサントの本音は、「今後は医療という大義名分に乗っかって、ビッグ4の世界市場の支配力を使いながら、今まで以上に幅広く大麻ビジネスをしたい」というものだという。さらにモンサントの背後には、陰謀論界隈で有名なあの「ロックフェラー一族」がいるという事実もこの合併の“不気味さ”に拍車をかけている。

　なにしろ、大麻という商品は、免罪符ともなる「医療用」として展開できる側面と、単に大麻を吸いたい潜在消費者の購買意欲を刺激できる側面を併せ持つ。世界大手の医療企業のマーケティング力を頼りに「医療のため」との看板を掲げ、世界のあちこちで合法的に大麻を売ることができる。モンサントに限らず、大麻ビジネスを推し進めたい企業にとっては、医療企業とのM&Aは格好の方法だろう。

■遺伝子組み換え大麻ビジネスが本格化する？　 　

さらに、モンサントの裏側を探ると、かなり興味深い事実が見えてくる。実はモンサントとガーデニング製品会社Miracle-Groとの間には、すでに業務提携が締結されていたのだった。

さらに、このMiracle-GroはHawthorneと業務提携を結び、Hawthorneを表立たせる形でBotanicare、Gavita、General Hydroponicsというオーガニック市場に強い3社を買い取らせた。 　

ちなみに、この3社は大麻生産をビジネスの柱にしているという。しかし、表面的にはモンサントとHawthorneは提携していないため、モンサントにしてみれば「うちの会社がこの3社やHawthorneと提携しているわけではない」と言い逃れができる。

 「Collective Evolution」によると、Miracle-GroのCEO 、ジム・ハーゲドルン氏は「5億円をこの事業につぎ込むべきです。こんな大きなビジネスチャンスは前代未聞ですよ」と周囲を説得し、「大麻ビジネスが巨大ブームに化ける足音を聞き逃すべきではない」との姿勢を示しているという。  

モンサントは3年前の時点で、ウルグアイにおける医療用大麻ビジネスに参入しているようだが、バイエルに買収された後、今まで以上に大麻ビジネスを拡大していくかどうかはまだ明かされていない。 　

しかし、世界的なビジネス展開の実行段階に至っていないとしても、モンサントの遺伝子組み換え技術を使えば大麻種子を大量に産出でき、バイエルのマーケティング網と特許を活用すれば、遺伝子組み換え大麻を合法的かつ世界的に売ることが可能になるという。

これは、かなり議論を呼びそうだ。 　実際に、こうした海外のサイトでさえ次のように締めくくっている。 「冷酷な商習慣を優先する企業に対し、消費者が声を上げていくことが必要だ。大麻が売れるかどうか、そのカギを握るのはモンサントでもバイエルでもなく、購買を決める消費者なのだ。消費者の力で、この大麻産業を食い止めるべきだ」 （文＝鮎沢明）

参考：「Collective Evolution」、ほか

緑内障、症状が出た時には視神経の半分死滅　自覚症状前の早期発見が鍵　3/25(日) 17:02配信 

　緑内障は、さまざまな原因で視神経が障害を受け視野が狭くなる病気で、失明に至ることもある。基本的な事を知らない人は、意外に多いようだ。名古屋市立大学病院長で同大大学院医学研究科視覚科学教授の小椋祐一郎氏は「恐ろしいのは、自覚症状が出た時には視神経の半分以上が死んでいることだ」と警鐘を鳴らす。

緑内障の啓発のため、グリーンにライトアップされた名古屋市の複合施設「オアシス21」（3月15日）

20人に1人の病気

　緑内障は、わが国の視覚障害の原因の第1位を占める。日本緑内障学会と岐阜県多治見市が2000年から01年にかけて同市で行った疫学調査によると、40歳以上の緑内障有病率は男女ともに5．0％だった。20人に1人という割合はかなり高いと言える。
　世界緑内障連盟と世界緑内障患者連盟が主体となり、08年から啓発のためのイベントである「世界緑内障週間」（18年は3月11～17日）を行っている。日本緑内障学会はこれに合わせ、国内のランドマークとなる施設を緑にライトアップする「ライトアップ　in　グリーン運動」を展開、名古屋市では学会と名古屋市立大学病院アイセンター、名古屋ウエストライオンズクラブの共催で、複合施設「オアシス21」などで実施された。小椋氏はこのイベントについて「残念ながら、緑内障に関する基本的な認識に欠ける人も多い。啓蒙（けいもう）が最大の目的だ」と開催の理由を説明した。
　目の病気では白内障と緑内障がよく知られているが、二つの病気は決定的に異なる。「白内障は手術をすれば視力が元に戻るが、緑内障は手術をしても欠損した視野は戻らない」。しかも、「緑内障は非常に慢性的に進む病気であるため、自覚症状がなかなか出ないことが問題だ」と指摘する。

名古屋市立大学病院長で同大大学院視覚科学教授の小椋祐一郎氏
正常眼圧でも緑内障に

　「ちょっと目の調子がおかしい、と思って眼科を受診する。しかし、その時には視神経の半分以上が駄目になっている。2～3割の視神経が死んでも、代償機能があるので気付かない」。さらにやっかいなのは、眼圧が正常範囲にありながら緑内障になる人がいることだ。多治見市における疫学調査の結果、緑内障の約70％がこの正常眼圧緑内障であることが分かったという。小椋氏は「それまでは、私たち専門医も『緑内障は眼圧が高い』と考えていたので、この調査のインパクトは大きかった」と振り返る。
　完治が期待できない緑内障の対策は、一にも二にも早期発見と早期治療によって病気の進行を止めるしかない。「眼圧と眼底を対象にした二つの検査で十分だ。これを1年に1回、定期的に受けてほしい。ただ、検査結果が全く正常であれば2年に1回でもよいだろう」と、小椋氏はアドバイスする。

点眼薬は3種類まで 　治療はまず薬物療法で、点眼薬から始める。内服薬を併用するケースもあるが、副作用を招く恐れがある。小椋氏は「1種類の点眼薬から開始し、効き目がなければ、2種類、3種類と増やしていく。ここ数年で良い薬が登場し、選択肢も増えた」とした上で、「患者の立場を考えれば、3種類が限度だろう。1日数回の点眼を、一生続けなければならないのだから。誤った考えで治ると思っている場合は、特につらいだろう」と語る。 　

薬物療法で進行が止められないときには、レーザー治療もしくは手術治療が必要だ。レーザー治療は外来で可能だが、手術は原則入院となる。目の中を流れる「房水」の流れが悪くなると、眼圧が上がる。そこで、手術により穴を開け、水を外に流す「バイパス」を作る。ただ、「1回の手術治療でうまくいくのは3分の2で、3分の1は2回以上の手術が必要になる」と指摘する。手術も進歩しており、「ここ数年で、以前と比べ切開創が小さくなり、新しい術式も出てきている」。小椋氏は「いずれにしろ、緑内障は早期発見が極めて大切だ」と重ねて強調した。（了）

Acquisitions and Growth Expand in Canadian Cannabis Market

NEWS PROVIDED BY CannabisNewsWire
Mar 08, 2018, 08:30 ET

NEW YORK, March 8, 2018 /PRNewswire/ --

CannabisNewsWire Editorial Coverage: 

The first wave of companies to enter the Canadian cannabis industry were grounded in medical marijuana, which was legalized in 2001. As the country prepares for legalized adult recreational-use this summer, new recreational brands are joining the scene, and many companies rooted in medicinal cannabis are taking action to participate in this second wave of the Canadian market. With its strong branding and modern store design, Choom Holdings, Inc. (CSE: CHOO) (OTC: CHOOF) (CHOOF Profile) is branded to appeal to the Canadian adult consumer ready to experience the cannabis lifestyle. Aurora Cannabis, Inc. (TSX: APH) (OTC: APHQF) is making strategic investments to establish footing in the recreational sector, while OrganiGram Holdings, Inc (TSX-V: OGI) (OTC: OGRMF) is taking measures to increase its production capacity ahead of a surge in product demand. Supreme Cannabis Company, Inc (TSX-V: FIRE) (OTC: SPRWF) has entered into multimillion-dollar agreements to supply cannabis to retail-oriented companies, and in Quebec, Hydropothecary Corp. (TSX-V: THCX) is expanding its greenhouse capacity to potentially increase its cannabis production to 30x its current volume.

Highs Coming for Canadian Cannabis

As established companies get serious about brand expansion, supply agreements, and potential retail revenues, investments within Canada's cannabis sector are soaring. The industry saw $1.2 billion investments in January alone - a 600 percent increase over the previous year - setting an incredible pace for continued growth. Currently, the State of California is the largest legal cannabis market in the world. With a population nearly as large as California's and an influx of cannabis capital, Canada is on track to potentially become one of the world's largest recreational-use markets. The country's combined medicinal and recreational market size is expected to reach $6 billion by the year 2021, surpassing the value of its whiskey and spirits industry.

While the Canadian cannabis industry has found impressive success with medicinal marijuana in recent years, a different approach will be needed to target recreational consumers. Cannabis producers that recognize this tremendous potential are pursuing investments in recreational brands that appeal to the retail market. One of Canada's most recognizable cannabis producers, Aphria, Inc. (TSX: APH) (OTCQB: APHQF), recently shelled out $230 million to acquire recreational brand Broken Coast - one of many M&A deals within the burgeoning industry.

A Relaxed Brand for a Relaxing Product

One of the new companies looking to stake a claim in the recreational market is Choom Holdings, Inc. (CSE: CHOO) (OTCQB: CHOOF). Choom is based in British Columbia, though its hip, modern brand has been designed around the tropical, relaxed ambiance of Hawaii. The company's name, "Choom", and style invoke Hawaiian culture, in particular easy days on the beach and in the countryside enjoying a casual atmosphere that connects with relaxation, which fittingly is one of the main appeals of cannabis. The company's name, Choom, which means "to smoke marijuana" - comes from a slang word used by a fun-loving group of friends (including former U.S. President Barack Obama) who grew up together in Hawaii during the 1970s.

This relaxed, friendly and informal approach to selling cannabis is designed to tap into a younger market with socially liberal values and disposal income to spare, and differs radically from the marketing focus of medical marijuana companies. The look and feel more closely resembles a food or alcoholic beverage brand, evoking warm feelings instead of healing/medicinal properties, which are the focus of established brands. In short, it's exactly the sort of approach the recreational cannabis industry will need.

Moving forward, the advantage in the legal cannabis sector seems likely to go to companies such as Choom, which are able to innovate with their branding, creating appealing lifestyle choices. Strict limitations on advertising cannabis will prevent the big medical marijuana players from using their financial clout to dominate the market through saturation advertising, which will create a space for young brands such Choom to grow via agile, modern techniques where traditional approaches aren't an option.

From Seed to Sale

Choom appears to have another market advantage with its vertical integration. The business has a seed-to-sale model that covers the whole cannabis pipeline, from growing and processing the plants to selling the final product in its own stores. This control over the entire business process allows the company to maximize efficiencies and ensure integration along the supply chain.

This advantage starts in the growing facilities, where Choom will fully oversee the growth of carefully crafted strains of cannabis. Existing facilities are planned for Vernon and Chemainus, Canada, to ensure that the company is prepared for the market as soon as possible. Choom is refitting both facilities, a process scheduled to be complete by July, with more than 13,000 square feet of growing space in planning.

Choom has announced a clear plan for its move into this market. With the Canadian cannabis market expected to see dramatic growth in early stages, the company has capacity to expand as needed. A second phase of expansion is in place for both facilities, which will significantly increase the growing space and allow for doubling crop yields by early 2019.

At the sale end of this supply chain are Choom's dispensaries, which are designed with a clean, stylish, and modern feel, much like a more relaxed version of an Apple store, a favorite of millennials and those with disposable income. These stores have been envisioned to appeal to two different but important market sectors. One is existing cannabis users, who will be looking for more convenient ways to buy their product once the law changes. The other is the group of "curious customers," who weren't willing to use cannabis while it was illegal but are interested in trying it now. Choom's relaxing retail space is designed to draw in customers from both sides, quickly building up a strong high street brand.

Preparing for Change

To power further growth, the company also recently completed a financing initiative, exceeding expectations and raising CAD $2.7 million (http://cnw.fm/AkT9x). The funds are being invested in advancing the company's development strategy, as well as for growth and acquisitions.

Having recently released the retail design for its dispensaries (http://cnw.fm/DIl3r), Choom is readying those facilities ready for legalization as well. And with the official launch of its retail program, the company has created the opportunity to develop a chain of branded cannabis dispensaries across Canada (http://cnw.fm/jqn8I).  

"Choom is using design and retail strategies that have worked successfully at some of the most profitable storefronts in the country. We are telling our Choom story with our stores and will elevate the concept of a high-quality product though our new retail environments, and we're inviting others to join us," Choom president and CEO Chris Bogart stated in the press release.

As the legal cannabis market prepares to open in Canada, Choom appears to have all the pieces in place to create a national premium recreation brand.

A Sector in Waiting

As the creation of Canada's legal recreational cannabis sector approaches, other companies are also preparing for the change.

One of Canada's biggest cannabis producers, Aurora Cannabis (TSX: APH) (OTCQB: APHQF), is investing in a range of related companies to set itself up for expansion into the recreational sector. The Vancouver-based organization has invested in The Green Organic Dutchman, a company that produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. It has also teamed up with Liquor Stores NA Ltd. to convert existing retail outlets into cannabis retail stores.

Another licensed producer of medical marijuana, OrganiGram Holdings (TSX-V: OGI) (OTCQB: OGRMF), recently received an expanded cultivation license from Health Canada, enabling the company to move forward with its expansion strategy that would increase current capacity from approximately 5,200 kg/year to an estimated 16,000 kg/year. Its longer-term plan is to increase production to 65,000 kg/year over the next two years.

Supreme Cannabis Company (TSX-V: FIRE) (OTC: SPRWF) has made its mission to grow sustainable cannabis companies to cater to the growing recreational market. To this end, it has invested in late-stage ACMPR applicant company BlissCo, and has agreed to provide cannabis to that company through its 7ACRES subsidiary. 7ACRES will also supply cannabis to Namaste subsidiary, Cannmart.

Quebec-based Hydropothecary (TSX-V: THCX) has signed a letter of intent with Société des alcools du Québec (SAQ) to supply 20,000 kg of cannabis to Quebec's recreational cannabis market in its first year of operation. This recent announcement follows news in December that the company added 78 acres of land adjacent to its existing 65-acre facility, and that it is working on a 1 million-square-foot greenhouse designed to increase its production to 108,000 kg per year, 30 times the current capacity.

Based on all forecasts, Canada's cannabis market is set for significant expansion in 2018. New actors and existing medical companies alike are preparing to seize this opportunity through production, distribution, and retail growth. With a clearly defined growth strategy, Choom Holdings is demonstrating its intention to rapidly become a recognizable national brand.

For more information on Choom Holdings, please visit Choom Holdings, Inc. (CSE: CHOO) (OTCQB: CHOOF).

About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today's market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text "Cannabis" to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with CNW or any company mentioned herein. The commentary, views and opinions expressed in this release by CNW are solely those of CNW and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW and FNM for any investment decisions by their readers or subscribers. CNW and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment.

CNW & FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW and FNM undertake no obligation to update such statements.

CannabisNewsWire (CNW) & NetworkNewsWire (NNW) are proud to be affiliated partners of the Investor Brand Network (IBN)

About IBN
Over the past 10+ years we have consistently introduced new network brands, each specifically designed to fulfil the unique needs of our growing client base and services. Today, we continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Please feel free to visit the Investor Brand Network (IBN) http://www.InvestorBrandNetwork.com


Corporate Communications Contact:
CannabisNewsWire (CNW)
Denver, Colorado
303-498-7722 Office
Editor@CannabisNewsWire.net

Media Contact:
FN Media Group, LLC
NNW@FinancialNewsMedia.com  
+1-(954)345-0611
www.CannabisNewsWire.com

SOURCE CannabisNewsWire

The brain link between coffee and cannabis 

Published Friday 16 March 2018 By Tim Newman Fact checked by Jasmin Collier 

Coffee is a complex substance and — as a new study finds — its metabolic interactions are equally complex. Surprisingly, coffee influences the same regions of the brain as cannabis.

A new study finds an intriguing relationship between cannabis and coffee.
Although studies looking at coffee's health benefits — or lack thereof — appear to be published on an almost daily basis, its true impact on health is still poorly understood.

Some studies have found health benefits, some have concluded that it might reduce mortality risk, and others drew no solid conclusions.

This confusion is due to several factors, and one is the difficulty in separating cause and effect in large, population-based studies. For example, someone who drinks a lot of coffee might also sleep less, smoke more tobacco, drink less water, or work unsociable hours. These factors muddy the statistical waters.

Also, coffee is an incredibly complex beast; it contains more than 1,000 aroma compounds, levels of which vary depending on the type of coffee bean and how it is brewed.


The metabolites of coffee
Recently, a group of researchers from Northwestern University in Chicago, IL, took a detailed look at the impact of coffee consumption on our internal chemistry. Their findings were published this week in the Journal of Internal Medicine.

The 3-month study involved 47 people living in Finland. In the first month, the participants drank no coffee at all; in the second, they consumed four cups every day; and in the third, they drank eight cups each day.


Cannabis intoxication may be stopped with anti-obesity drug
Researchers may have found an antidote to cannabinoid intoxication.
READ NOW
Using advanced profiling techniques, lead author Marilyn Cornelis and her team checked the levels of more than 800 metabolites in the blood after each stage. Metabolites are chemicals produced during metabolism. They are generally small molecules and carry out a range of functions both within and between cells.

The scientists found that with increased coffee consumption, blood metabolites involved in the endocannabinoid system dropped off. This is the system that gives cannabis its recreational and medical effects.

Interestingly, the effect of coffee consumption on the endocannabinoid system was the opposite to cannabis use: endocannabinoid neurotransmitters decreased with the consumption of eight cups per day, but levels are increased by cannabis use.


Endocannabinoids may answer queries
The endocannabinoid system helps to modulate a whole host of metabolic activities — including blood pressure, cognition, addiction, immunity, appetite, sleep, and glucose metabolism. So, if coffee influences this overarching system, it will open up many new research avenues.

"These are entirely new pathways by which coffee might affect health," notes Cornelis. "Now, we want to delve deeper and study how these changes affect the body."

For instance, the endocannabinoid system is believed to influence eating behavior. As Cornelis says, this could help to explain "the link between cannabis use and the munchies." Conversely, coffee has been considered a potential weight loss aid and may reduce type 2 diabetes risk.

"This is often thought to be due to caffeine's ability to boost fat metabolism or the glucose-regulating effects of polyphenols (plant-derived chemicals)."

Marilyn Cornelis
"Our new findings linking coffee to endocannabinoids," she adds, "offer alternative explanations worthy of further study."

Drinking more coffee was also found to increase metabolites from the androsteroid system. This infers that coffee speeds up the excretion of steroids. And, because steroids are involved in a number of conditions — notably cancers — coffee could, potentially, play a part here, too.

This study was the first to have demonstrated such a depth of metabolic interaction between coffee and the endocannabinoid system. No doubt these new learnings will form the foundations of future research into a range of conditions.

However, more work will be needed to understand whether the observed changes in metabolites were due to caffeine or one of the myriad other compounds in those cups of delicious black gold.

Lifestyle #BigBusiness  MAR 12, 2018 @ 06:00 AM 2,197 
This Is Where To Find The Most Available Cannabis Industry Jobs

It’s Monday. That dastardly alarm clock starts screaming at the crack of dawn to let you know that it is time to get up for work. You hit to snooze button – And I mean you really let it have it – before pulling the covers up over the top of your head to ponder, and quite possibly even dread, the weight of the day ahead. By the time the alarm chirps a second time, the impending doom has fully infiltrated your psyche and begins trying to convince you that if you quit that measly job today, you’ll be able to find a better one within a week. You hit the snooze again, giving yourself approximately ten extra minutes to decide whether to climb out of bed and put on pants or call up the big boss man and say, “Hey man, it’s been real, but I no longer wish to work for you.” Your version might contain more colorful language. But for the sake of this article, lets keep it classy.

At that point you realize a proper head change might help provide you with the enthusiasm needed to go from “hating” your place of employment to tolerating it for at least another eight hours. You pick up the bowl off the nightstand, which you loaded the night before with a nice strain of cannabis, and engage in a much-needed wake and bake ritual. This is your Hail Mary. Otherwise, you might actually phone that boss of yours in the next couple of minutes and tell him to “take this job and shove it.” You take a couple of nice hits and consider once again the act of getting out of bed. All of sudden an epiphany strikes – eureka! “If only I could get a job working in the cannabis industry,” you tell yourself. “I would never be unhappy with the daily grind ever again.”

This situation is not uncommon. A 2017 Gallup poll found that 85 percent of the American workforce “hates” their job. Alongside the complaint of not earning enough money, most workers argue that their current position leaves them overworked and unfulfilled. In other words, they feel just like you do.


But the cannabis industry is not only providing people with interesting career options, it pays more than the average salary. It is for this reason that some restaurants in legal marijuana states are reportedly having difficulty finding and keeping employees. After all, why settle for minimum wage to wash dishes all day when the starting wages at some cultivation centers is between $12-$15 per hour? What’s more is prospective cannabis industry employees are not required to have any formal education or training to secure these new positions. They just have to be in the right place at the right time. But where is that exactly?

Marijuana is now legal in well over half the nation. Twenty-nine states and the District of Columbia have legalized for medicinal use, while eight others have ended marijuana prohibition altogether. At a time when some traditional industries are facing downsizing and extinction, the cannabis industry is just getting started – and it’s showing no signs of a slow down. In fact, some of the latest data From New Frontier shows there will be more cannabis industry jobs available in the next couple of year than the combination of the government and manufacturing sector. It is a possible a quarter of a million new jobs will be filled by 2020 to keep the multi-billion dollar cannabis industry afloat.

According to ZipRecruiter, cannabis industry jobs are easier to come by in some areas than others. But positions in this field are becoming more widespread. Last year represented the biggest gain in cannabis employment since the walls of prohibition started to crumble. Interestingly, the website says hundreds of new positions are being posted each quarter for workers interested in a career in the cannabis trade. Already in 2018, the cannabis job market is off to a lunatic start. This mostly stems from the recent launch of California’s recreational marijuana market. But there are 10 cities in the nation where workers can find the most opportunity in the business of growing and selling weed. Here's where you might have the best luck:

Top 10 Cities To Find Work In The Cannabis Industry

Denver, Colorado
Los Angeles, California
San Francisco, California
Seattle, Washington
Portland, Oregon
Sacramento, California
Spokane, Washington
Miami, Florida
Chicago, Illinois
Boston, Massachusetts 

The marijuana job market is presently out pacing other leading fields, like tech and healthcare. There are now in upwards of 230,000 people collecting a paycheck for their work in legal cannabis. A recent report from Arcview Market Research predicts there will be 400,000 cannabis workers by 2021..........

 スナック菓子・ブラウニー…多様化する大麻、乱用の懸念
伊藤和也 2018年3月28日17時11分

関東信越厚生局麻薬取締部横浜分室が押収したスナック菓子
関東信越厚生局麻薬取締部横浜分室が押収したブラウニー

　スナック菓子にチョコレート、電子たばこのようにして使う液体の「リキッド」……。大麻が近年、様々に形を変えて広がっている。こうした「大麻製品」は、含まれる幻覚成分の濃さの割に手を出しやすく、乱用が懸念されている。

　財務省関税局によると、全国の税関が水際で摘発したチョコレートやクッキー、グミなどの菓子類やリキッドなど大麻製品は、４年前から急増。最も多かった２０１５年で２４件に上った。１６、１７年は各９件。１１～１３年は年間１～２件にとどまっていた。危険ドラッグ対策が１４年に本格化した影響もあるとみられる。

　国内で押収される例も目立つ。関東信越厚生局麻薬取締部横浜分室は今年に入り、違法薬物事件の捜査の過程で、スナック菓子やブラウニーを押収した。

　専用の器具を取り付けて熱し、煙を吸い込んで使うリキッドは、大麻に含まれる幻覚成分を濃縮して精製する。横浜分室が鑑定したところ、成分濃度が乾燥大麻の葉（０・５～５％）や花（１２～１６％）を大幅に上回り、７０％に達するものもあったという。菓子類は海外で医療用などで使われているものも多いという。

　乾燥大麻から幻覚成分を抽出した「大麻ワックス」の摘発も相次いでいる。（伊藤和也）

　　　　　◇

　《国立精神・神経医療研究センターの舩田（ふなだ）正彦室長の話》　リキッドはもはや大麻というより人工の薬物に近い。幻覚成分が濃縮されており、通常では考えられない影響を心身にもたらすリスクがある。菓子類は抵抗感が薄いまま安易に手を出してしまいやすく、より作用の強いものを求めるきっかけになり得る。大麻は依存性があり、やめられなくなって意識障害や認知機能の低下を引き起こす恐れがあるので注意が必要だ。

President Trump is reportedly weighing a plan to fire U.S. Attorney General Jeff Sessions and potentially replace him with Scott Pruitt, who currently leads the Environmental Protection Agency. Marijuana industry operators and consumers might initially breathe a sigh of relief at the prospect of Sessions leaving the Justice Department, since it is difficult to imagine …

Pot Grower Green Organic Raises C$100 Million in IPO
By Scott Deveau

2018年3月23日 23:45 GMT+5:30

Equity raise comes in at the top end of the expected range
Green Organic Dutchman sells shares at C$3.65 a piece
Medical marijuana grower Green Organic Dutchman Holdings Ltd. raised C$100 million ($78 million) in its initial public offering, according to a person familiar with the matter.

The raise by the Mississauga, Ontario-based pot producer came in at the high end of the previously disclosed range of C$75 million to C$100 million. The company priced its shares at C$3.65 apiece and is expected to begin trading next week in Toronto.

The sale was several times oversubscribed and the over-allotment is also expected to exercised, bringing total proceeds to about C$115 million, said the person, who asked not to be identified because the matter is private.

A spokesman for the company couldn’t be reached for comment.

The IPO follows the January listing by pot producer MedReleaf Corp., which fell 22 percent on its first day of trading. That was the largest decline in 16 years for a Canadian IPO larger than C$100 million.

Green Organic’s IPO was led by Canaccord Genuity Corp. and PI Financial Corp. The company intends to use the proceeds from the offering to fund its ongoing operations, according to a a regulatory filing. It said that will include completing its facilities in Hamilton, Ontario, and Salaberry-de-Valleyfield, Quebec, as well as funding various licensing and approvals, it said.

Quotes from this Article

LEAF:CN　Toronto MedReleaf Corp 17.76CAD

Medical marijuana patients and providers in a growing number of states will be safe from federal prosecution until at least September under a new congressional spending bill.

Innovative Industrial Properties declares $0.25 dividend
Mar. 15, 2018 7:21 AM ET|

About: Innovative In... (IIPR) 

Innovative Industrial Properties (NYSE:IIPR) declares $0.25/share quarterly dividend, in line with previous.

Forward yield 3.59%

Payable April 16; for shareholders of record March 29; ex-div March 28.

Now read: Marijuana Grow House REIT May Have Its Ups And Downs, But It Has High Side Potential »

Top Marijuana Stocks   Author: StockTwits

A wave of legalization is sweeping the nation, and these marijuana (and tobacco) stocks could reap some high rewards.

In this list: 

$GWPH, $INSY, $CARA, $MO, $ABBV, $SMG, $ZYNE, $PM, $VGR, $AOI, $APH.CA, $WEED.CA, $CMED.CA